Bioxcel Therapeutics Logo

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence.

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our Approach to Drug Development

AI-Driven Transformative Medicines in Neuroscience

We utilize our unique and proprietary AI platform to identify, re-innovate, and develop potential new therapies 

Latest News

Mar 01, 2024
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024VIEW RELEASE
Feb 13, 2024
BioXcel Therapeutics Announces Termination of Proposed Public OfferingVIEW RELEASE
Feb 12, 2024
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)VIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Mar 04, 2024 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

3.12

CHANGE

0 (0%)
Scroll to Top

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical andregulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US and Bioxcel Therapeutics authorized persons find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.